Durability of Antibody Responses to SARS-CoV-2 Infection and Its Relationship to Disease Severity Assessed Using a Commercially Available Assay
Microbiology
[키워드] Anti-spike
antibody
Antibody titer
Assessing
Asymptomatic
asymptomatic patients
automated
both group
circulation
Cohort
collected
commercial assay
correlated
correlation
COVID-19 infection
determine
DiaSorin
different time point
disease severity
distribution
Durability
Efficacy
enrolled
evaluated
faster
female
Gender
humoral immune response
ICU patient
ICU Patients
IgG
IgG titer
immune response
individual
Infection
LIAISON
majority
male
median
mounted
much higher
non-ICU
occurred
Older age
onset of symptom
participant
Participants
patients with COVID-19
PCR
PCR-confirmed COVID-19
platform
polymerase chain
positive
positive PCR
protective immunity
Protein
rate of seroconversion
Reinfection
relationship
response
S1/S2
SARS-CoV-2
SARS-CoV-2 antibody
SARS-COV-2 infection
Seroconversion
seroconversion rate
significantly
significantly higher
subject
symptomatic and asymptomatic
symptomatic participant
tested
the median
Vaccine
[DOI] 10.3389/fmicb.2021.770727 PMC 바로가기 [Article Type] Microbiology
[DOI] 10.3389/fmicb.2021.770727 PMC 바로가기 [Article Type] Microbiology